Background {#Sec1}
==========

In Europe and some parts of Asia, Tick-borne encephalitis (TBE) is a very important viral tick-borne zoonosis \[[@CR1]\], and the TBE virus (TBEV), a flavivirus, occurs in so-called "natural foci", whose size can range from large to very small. TBEV circulates especially between small mammals as local hosts and ticks as arthropod vectors. A large variety of mammalian species may become infected, and human TBE infections are notifiable in most endemic countries. Despite the reported human cases, symptomatic infections are also known (but very seldom) in dogs \[[@CR2]\], horses \[[@CR3]\], monkeys \[[@CR4]\], and in single cases in sheep, mouflons and goats \[[@CR5]--[@CR7]\].

In addition, seroconversion without any specific clinical signs of a TBEV infection is described in some livestock animal species such as cattle, small ruminants and pigs \[[@CR8]--[@CR11]\]. In previous studies, TBEV-specific antibody titers in both goats and sheep were detected for up to 28 months after immunization, and cross reactivity against other related pathogens was very low \[[@CR12]\]. Furthermore, grazing animals have been shown to be suitable sentinels for the detection of TBEV foci by serological surveillance \[[@CR9]\].

Especially the infection of ruminants is relevant for public health: in goats and sheep, and more rarely also in cattle, TBEV can be excreted via milk for several days after infection. Viraemia was observed between one and 5 days, TBEV was excreted via milk some days longer for two to 7 days in subcutaneously infected sheep \[[@CR13]\], in subcutaneously infected cows TBEV could be detected for two to 4 days after infection in the blood and for three to 5 days in the milk \[[@CR14]\]. After infection of a goat reported by van Tongeren \[[@CR15]\], TBEV was detected in the blood from one to 5 days, from three to 8 days in the milk. Nearly the same results for sheep and a cow were reported by Grešíková and Rehacek after infection via tick bite \[[@CR16]\]. Balogh et al. \[[@CR17]\] detected TBEV in milk between eight and up to 19 days after experimental infection of goats. In the last 20 years, human cases of alimentary TBE have been reported from several countries including Hungary, Austria, Estonia, Slovakia \[[@CR18]--[@CR21]\] and very recently also in Germany \[[@CR22]\].

The TBEV antibody status of a flock can help evaluate a possible risk of alimentary TBE caused by raw milk from this flock. In this study, (i) 50 goat flocks with 735 animals from the federal states of Bavaria (BY), Baden-Württemberg (BW), Lower Saxony (LS) and Mecklenburg-West Pomerania (MV) were evaluated with regard to TBEV antibodies to estimate the risk of TBEV infection in animals that can cause TBEV excretion via milk for several days.

As described above, knowledge about clinical symptoms, immune response and cross reactivity and longevity of antibody response as well as about the epidemiology of TBEV in animals has increased over the last years. However, some basic questions still remain unanswered or have been incompletely addressed. One relevant parameter is e.g. the longevity of TBEV-specific immunity. In our study, (ii) longevity was observed for more than 6 years. Furthermore, it is unknown whether contact to TBEV causes a long-lasting immunological memory that is reactivated quickly by any further contact to TBEV. Therefore, (iii) this possible recall of immunological information was tested by an additional immunization 5 years after the first TBEV contact.

Results {#Sec2}
=======

TBEV-antibody positive samples in the selected goat flocks {#Sec3}
----------------------------------------------------------

In the period from 2013 to 2015, we investigated 735 plasma samples from 50 goat flocks from four different federal states in Germany. The sample panel for the entire three-year period was available only from BY (see Table [1](#Tab1){ref-type="table"}). The serological results are as follows: for MV from overall 205 samples in nine flocks only one goat was positive with a very low TBEV-titer (ND~50~ 1:10). A similarly low titer (ND~50~ 1:30) only was detectedin one goat from LS with overall 126 animals from nine flocks investigated and in one goat from BY (ND~50~ 1:30) with overall 230 animals from 21 flocks tested over 3 years. In contrast, the results from BW: in 2013, three goats out of 69 animals from a total of three herds were tested positive, with two goats from the same herd showing significantly higher titers (ND~50~ 1:160 and 1:320). The remaining goat had a titer of ND~50~ 1:20. Similar results could also be seen for 2015 in BW, where a total of 105 samples from eight herds were tested. Here, four positive goats from one herd were determined, which also had very high TBEV titers (ND~50~ 1:120, 1:120, 1:160 and 1:480), see Table [1](#Tab1){ref-type="table"}. Table 1Origin and serological results of the goat samples201320142015totalMV flocks9----9MV samples205----205MV TBEV pos.1----1MV SNT titer (ND~50~)1:10LS flocks27--9LS samples7749--126LS TBEV pos.10--1LS SNT titer(ND~50~)1:30BW flocks3--811BW samples69--105174BW TBEV pos.3^a^--4^b^7BW SNT titer(ND~50~)1:20, 1:160, 1:3202 × 1:120, 1:160, 1:480BY flocks128121BY samples11510510230BY TBEV pos.0101BY SNT titer(ND~50~)1:30^a^two positive samples from the same flock^b^all four positive samples from the same flock*MV* Mecklenburg-West Pomerania, *LS* Lower Saxony, *BW* Baden-Württemberg, *BY* Bavaria

Before starting, positive sera and plasmas from goats were tested for their suitability by TBEV-VNT. No deviations between sera and plasmas were seen, and both starting materials could be used equally well (data not shown).

Longevity of TBEV-specific antibody titers in immunized animals {#Sec4}
---------------------------------------------------------------

In the previous study, titers increased in the vaccinated sheep and goats until 18 weeks after the first immunization and decreased over the following weeks to reach lower but still positive titers 28 months after vaccination \[[@CR12]\]. Here in the following months, the titers further decreased but were detectable in goats for the whole observation period (6 years and 10 months). Overall, one sheep was tested positive up to 3 years and 6 months, the other one up to 4 years and 7 months.

TBEV antibody titers of these four multiple vaccinated animals and of four additional single vaccinated animals without previous contact to TBEV are shown in Table [2](#Tab2){ref-type="table"}. VNT titers detected in sera of the animals immunized years before (multiple vaccinated) after one, two and 3 months ranged between 1:5 and 1:160. Generally, VNT titers in goat sera were higher when compared to titers detected in the sheep sera. In addition, the two goat sera revealed reactive TBEV antibody titers already 1 week after booster immunization. In contrast, three of the four naïve animals developed only low antibody titers (up to 1:15) after immunization, while one sheep did not display a positive TBEV antibody titer at all. Table 2Boost of TBEV-antibody titers (VNT) in pre-immunized goats and sheep^a^time point after last immunizationmultiple vaccinatedsingle vaccinatedgoat 1goat 2sheep 1sheep 2goat 3goat 4sheep 3sheep 41 week1:401:10\< 1:5\< 1:5\< 1:5\< 1:5\< 1:5\< 1:51 month1:1131:801:1601:1601:151:7.51:10\< 1:52 months1:801:28.21:151:1601:15\< 1:5\< 1:5\< 1:53 months1:28.21:801:51:28.21:7,51:5\< 1:5\< 1:5^a^VNT titers of all animals \< 1:5 before immunization

All results were obtained either with blood samples collected for other usages (see ethics statement) or with only eight animals kept in one flock at the FLI. At present animal samples cannot be replaced completely for these investigations. In the study the number of animals was minimized and all procedures (only subcutaneous immunization and collection of blood samples) were refined.

Discussion {#Sec5}
==========

Our field study for the evaluation of goat flocks in Germany showed a TBEV seropositivity in single animal samples only. Most of the identified TBEV-reactive goats were found in Baden-Württemberg (11 flocks with 174 tested animals) with eight TBEV antibody-positive sera (4.6%). In Bavaria, Mecklenburg-West Pomerania and Lower Saxony only a single TBEV antibody positive sample could be detected (0.43, 0.49 and 0.78% of all tested samples, respectively). These results clearly show that even in grazing animals in the selected regions, contact to TBEV via tick bites is seldom and therefore the general risk of alimentary TBEV infection for humans is low. However, within a spatial TBEV natural focus the local risk of an alimentary TBEV infection can be remarkably higher. Since these foci can be very small, it is possible that only one ruminant flock is involved and that this particular flock has a high risk of TBEV infections. One single flock in Baden-Württemberg exhibited e.g. four of the eight TBEV antibody-positive samples. This is in accordance with our own findings in a previous study with 3590 sera from sheep and 3793 sera from goats in 2003 and 2006--2009 in seven federal states of Germany with in general low seroprevalences for the whole state. However, in single flocks in the same village seroprevalences between 0 and 43% were seen which confirmed the patchy pattern of TBEV \[[@CR9]\]. Nearly the same differences between 2% (Mureş County) and 27.73% (Bihor County) seropositive sheep were found in Romania with a higher prevalence than in our investigated samples of 15.2% of all tested 519 samples in Romania \[[@CR23]\]. A low overall seroprevalence was seen in Lithuanian domestic ruminants of 1.7% in eight out of 18 checked regions with high regional differences. Sheep from one region had the highest rate of 16% \[[@CR24]\].

In a TBEV-positive case, it is highly recommended to test all milk and milk products from the affected flock for TBEV and to conduct further epidemiological investigations including anamnestic information about the purchase of animals from other regions with a known TBEV risk. Unfortunately, such information was not available for this study. A nationwide database of small ruminants, equally structured as for bovines, could help in this context to provide more background information for the veterinary authorities. A clearly worthwhile recommendation with regard to such a flock is to sell only pasteurized milk and milk products to avoid any cases of alimentary TBEV.

We could also show that reactive antibodies against TBEV last very long after immunization, and immunized goats displayed a positive reaction for nearly 7 years. In sheep, this time span was considerably shorter (3 years and 6 months and 4 years and 7 months). In our study highest titers were seen around 13 weeks after the first dose (all together four doses) of a vaccine produced for humans and based on TBEV strain Neudoerfl \[[@CR11]\]. With three doses of a new vaccine candidate for veterinary use by Salát et al. \[[@CR25]\] the highest titers were observed around 42 days after first immunization with higher VNT titers like in our study \[[@CR11]\]. This vaccine based on TBEV strain Hypr and may cause even better immunity in animals like our vaccine for human use. This should be tested in further investigations.

Interestingly, even after years the small ruminants exhibited a clear immunological recall reaction as demonstrated by the increasing antibody titers in response to administration of one dose of vaccine. This contrasted very well the sero-reactions detected in the four naïve control animals with low or no antibody response after immunization with a single dose of the vaccine.

In this study, the progress of TBEV antibody titers reflects the situation after immunization with an inactivated vaccine, however natural infection may result in relatively similar humoral immune responses, as already shown for horses and dogs \[[@CR2], [@CR3]\]. However, the duration of immunity could be different between booster-vaccinated animals and animals after natural TBEV-infection. A fact which should be also taken into consideration.

Conclusions {#Sec6}
===========

TBEV-specific antibodies in grazing animals are not widespread, however, in some single flocks a remarkable number of seropositive animals indicate contact of the flock to TBEV. Consequently, a high risk of alimentary TBEV from non-pasteurized milk and milk products must be assumed in these flocks. In these cases epidemiological investigations like testing ticks from the meadows used by the flock for TBEV-RNA, avoiding meadows with TBEV-positive ticks and strict pasteurization of the milk before consumption are highly recommended.

We could also show that immunized goats and sheep had long-lasting TBEV-specific antibody titers, in our study between 3 years and 6 months and 6 years and 10 months. A boost immunization years after the first immunization demonstrated efficient immunological recall reactions.

Finally, it can be concluded that for organic farms selling fresh milk and milk products to private consumers the immunization of milking goats and sheep also could be an alternative to minimize the risk of an alimentary TBEV-infection.

Methods {#Sec7}
=======

Collection of samples {#Sec8}
---------------------

### Samples from goat flocks {#Sec9}

Between 2013 and 2015, blood samples (in particular plasma) were collected from a variety of goat breeds raised in nearly all federal states of Germany (excluding the cities Berlin, Hamburg and Bremen). The blood samples from four different federal states selected for this project were prioritized based on the continuous annual occurrence of TBEV in ticks and humans in southern Germany and recent cases of alimentary raw milk infections in humans \[[@CR22]\]. In contrast, TBEV detection in ticks in central and northern Germany is rather sporadic and more locally restricted. All examined goat samples have in common, that contact of the animals with grassland and pastures was possible. Therefore, our extracted panel of 735 blood samples focused on the federal states BY, BW, LS and MV. More details with regard to the number of goat flocks and samples for each federal state and for each year are summarized in Table [1](#Tab1){ref-type="table"}. All animals remained in their flocks of origin. No anaesthesia or euthanasia methods were used.

### Sera collected to analyse the longevity of the humoral immune response {#Sec10}

Two goats and two sheep were immunized four times with FSME-IMMUN Erwachsene (Baxter Deutschland GmbH, Unterschleißheim, Germany), a vaccine available for humans, as described by Klaus et al. \[[@CR11]\], at weeks 0, 1, 3 and 11. The vaccine contains inactivated TBEV, strain Neudoerfl. At each immunization one dose of 0.5 ml containing 2.4 μg inactivated virus antigen was injected subcutaneously per goat and sheep. This dose is also used routinely for adult humans according to the manufacturer's vaccination recommendations. All animals were observed for clinical signs of illness or allergic reactions as well as for a potential increase of body temperature at least 2 days before and 2 days after immunization. Neither clinical nor allergic signs were observed, and body temperature was normal at all times. According to the manufacturer's instructions three immunizations were recommended in humans for a good immune response. However, in previous studies single animals showed delayed reactivity compared to the others and needed four immunizations to develop TBEV specific antibodies. Therefore, it was decided to immunize all animals four times \[[@CR11]\]. TBEV antibody titers were traced over a period of 6 years and 10 months.

In order to check a possible recall of immunological information after nearly 7 years, these individual animals were booster immunized with one dose of "FSME-IMMUN Erwachsene" (Baxter Deutschland GmbH, Germany) subcutaneously, and as an additional control, two naïve goats and sheep were also immunized with one dose of the same vaccine. After (booster) immunization, TBEV titers weretraced for 3 months. All eight animals were kept in the same flock at the Friedrich-Loeffler-Institut (FLI) without pathogen contact in a natural TBEV focus. These animals were owned by the FLI and lived in one flock grazing on FLI owned meadows, with access to hay and concentrated feed stuff. No anaesthesia or euthanasia methods were used in any of the flocks. All animals were female, at the beginning of the first immunization between eight to 10 months old, at the time of boost immunization 7 years old, with a weight between 83 and 118 kg. Animal health status was checked daily. No health problems occurred during the whole study period.

All animal experiments were conducted at a high standard of veterinary care and were approved by the competent authorities.

Test systems {#Sec11}
------------

### TBEV specific serology {#Sec12}

For the detection of TBEV antibodies we analysed all plasma samples from goats in a specific virus neutralization test (VNT) by using TBEV strain "Neudoerfl" (kindly provided by F. Hufert, Institute for Virology, Göttingen Germany; GenBank accession no. U27495).

The VNT was performed as already described by Seidowski et al. \[[@CR26]\] and Ziegler et al. \[[@CR27]\], only the virus strain (TBEV) was modified. Briefly, all samples were run in duplicate and at a starting plasma dilution of 1:10 and a virus concentration of 100 TCID~50~/well. The applied cells were Vero B4 (Collection of Cell Lines in Veterinary Medicine, Friedrich-Loeffler- Institut, Germany), cytopathic effects were revealed 6--7 days postinfection, and VNT titers were calculated. The neutralizing antibody titers (ND~50~) were expressed at the reciprocal of the plasma dilution that still inhibited \> 50% of cytopathogenic effect, calculated according to the Behrens-Kaerber method. Plasma samples with ND~50~ values above 10 were determined as positive; samples with a lower titer than 10 were determined as negative.

Sera of immunized goats and sheep from the second and third part of this study were examined by virus neutralization test as described previously \[[@CR28]\], virus strain Langat was used in the test. Here, serum samples with ND~50~ values above 1:5 were determined as positive; samples with a lower titer were classified as negative.
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